Galena Biopharma Bolsters NeuVax(TM) (nelipepimut-S) Intellectual Property With Patent Acceptance in Australia

Galena Biopharma Bolsters NeuVax(TM) (nelipepimut-S) Intellectual Property With Patent Acceptance in Australia

[at noodls] – PORTLAND, Ore., Feb. 28, 2014 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major … more

View todays social media effects on RXII

View the latest stocks trending across Twitter. Click to view dashboard

See who RXi is hiring next, click here to view

Share this post